CH624395A5 - - Google Patents
Download PDFInfo
- Publication number
- CH624395A5 CH624395A5 CH16176A CH16176A CH624395A5 CH 624395 A5 CH624395 A5 CH 624395A5 CH 16176 A CH16176 A CH 16176A CH 16176 A CH16176 A CH 16176A CH 624395 A5 CH624395 A5 CH 624395A5
- Authority
- CH
- Switzerland
- Prior art keywords
- formula
- group
- compounds
- salts
- acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
- C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
- C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
- C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (43)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH16176A CH624395A5 (el) | 1976-01-08 | 1976-01-08 | |
US05/751,233 US4140789A (en) | 1976-01-08 | 1976-12-16 | Etherified hydroxy-benzodiheterocyclic compounds |
AR265940A AR214869A1 (es) | 1976-01-08 | 1976-12-21 | Procedimiento para la elaboracion de compuestos sustituidos por(3-amino-2-hidroxi-propiloxi)de la benzimidazol-2-ona,2-(3h)-benzoxazolona,(1h)(3h)-quinazolin-2,4-diona,3,4-dihidro-1h-quinazolin-2-ona,1,2,3,4-tetrahidro-2,3-dioxo-quinazolina,2,3-dihidro-4h-benze(5,6)oxazin-3-ona y 4h-1,3-benzoxazin-2(1h)-ona |
GB53633/76A GB1549945A (en) | 1976-01-08 | 1976-12-22 | Etherified hydroxy-benzodiheterocyclic compounds |
NZ182963A NZ182963A (en) | 1976-01-08 | 1976-12-22 | C-(3-alkylamino-2-hydroxypropoxy)benz(diaza or azaoxa)-cycloalkan-2-ones |
DE19772700193 DE2700193A1 (de) | 1976-01-08 | 1977-01-04 | Veraetherte hydroxy-benzodiheterocyclen |
ES454779A ES454779A1 (es) | 1976-01-08 | 1977-01-04 | Procedimiento para la obtencion de hidroxidiheterociclos eterados. |
SE7700056A SE7700056L (sv) | 1976-01-08 | 1977-01-04 | Foretrade hydroxibensidiheterocykler |
IL51222A IL51222A (en) | 1976-01-08 | 1977-01-06 | Etherified hydroxy-benzodiheterocyclic compounds,their prearation and pharmaceutical compositions containing them |
PL1977195154A PL110654B1 (en) | 1976-01-08 | 1977-01-06 | Method of producing new ethers of hydroxy-benzodiheterocyclic compounds |
DD7700196843A DD129444A5 (de) | 1976-01-08 | 1977-01-06 | Veraetherte hydroxy-benzodiheterocyclen |
FI770036A FI770036A (el) | 1976-01-08 | 1977-01-06 | |
FR7700232A FR2337718A1 (fr) | 1976-01-08 | 1977-01-06 | Nouveaux hydroxy-benzodiheterocycles etherifies, leur procede de preparation et leur application en tant que medicaments |
PL1977214709A PL112441B1 (en) | 1976-01-08 | 1977-01-06 | Process for preparing novel ethers of hydroxy-benzodiheterocyclic compounds |
PL1977214710A PL112442B1 (en) | 1976-01-08 | 1977-01-06 | Process for preparing novel ethers of hydroxy-benzodiheterocyclic compounds |
PT6603677A PT66036A1 (en) | 1976-01-08 | 1977-01-06 | Process for preparation of etherified hydroxibenzodiheterocyclic compounds |
PL1977214708A PL112491B1 (en) | 1976-01-08 | 1977-01-06 | Process for preparing novel ethers of hydroxy-benzodiheterocyclic compounds |
CA269,205A CA1083150A (en) | 1976-01-08 | 1977-01-06 | Process for the manufacture of etherified hydroxy- benzodiheterocyclic compounds |
AU21105/77A AU507884B2 (en) | 1976-01-08 | 1977-01-06 | Etherified hydroxy-benzodiheterocyclic compounds |
CS77117A CS201040B2 (en) | 1976-01-08 | 1977-01-07 | Method of producing etherified hydroxy-benzo-diheterocyclic compounds |
BE173895A BE850166A (fr) | 1976-01-08 | 1977-01-07 | Nouveaux hydroxy-benzodiheterocycles etherifies |
AT4677A AT355564B (de) | 1976-01-08 | 1977-01-07 | Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen,-benzoxazolonen,- benzoxazinonen,-chinozolinonen und-chino- xalinonen |
SU772435952A SU648091A3 (ru) | 1976-01-08 | 1977-01-07 | Способ получени этерифицированных окси-бензодигетероциклов или их солей, или рацематов, или оптически активных антиподов |
ZA770087A ZA7787B (en) | 1976-01-08 | 1977-01-07 | Etherified hydroxy-benzodiheterocyclic compounds |
IE31/77A IE44246B1 (en) | 1976-01-08 | 1977-01-07 | Etherified hydroxy-benzodiheterocyclic compounds |
DK6177A DK6177A (da) | 1976-01-08 | 1977-01-07 | Foretherede hydroxy-benzodiheterocycler eller salte deraf og fremgangsmade til fremstilling deraf |
NO770061A NO770061L (no) | 1976-01-08 | 1977-01-07 | Foretrede hydroksy-benzodiheterocykler. |
NL7700141A NL7700141A (nl) | 1976-01-08 | 1977-01-07 | Heterocyclische benzoverbindingen met een ver- etherde hydroxylgroep. |
JP55977A JPS5285166A (en) | 1976-01-08 | 1977-01-08 | Production of etherified hydroxyybenzodiheterocyclic compound and pharmaceutical composition |
GR52536A GR73132B (el) | 1976-01-08 | 1977-01-08 | |
AR268660A AR214746A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-onas y 5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolinas |
AR268662A AR217258A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de compuestos(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,2(3h)-benzoxazolona,(1h)(3h)-quinazolin-2,4-dional,3,4-dihidro-1h-quinazolin-2-ona 1,2,3,4-tetra-dihidro-2,3-dioxo-quinazolina,2,3-hidro-4h-benz(5,6)oxazin-3-ona y 4h-1,3-benzoxazin-2(1h)-(ona) |
AR268661A AR215643A1 (es) | 1976-01-08 | 1977-08-02 | Procedimiento para la elaboracion de compuestos de 4-(3-amino-2-hidroxi-propiloxi)-benzimidazol-2-ona,5-(3-amino-2-hidroxi-propiloxi)-3,4-dihidro-1h-quinazolin-2-ona,5-(3-amino-2-hideoxi-propiloxi)-(1h)(3h)-quina-zolin-2,4-diona,7-(3-amino-2-hidroxi-propiloxi)-2(3h)-benzoxazolona,5-(3-amino-2-hidroxi-propiloxi)-1,2,3,4-tetrahidro-2,3-dioxo-quinoxazolina,8-(3-amino-2-hidroxi-propiloxi)-2,3-dihidro-4-h-benz(5,6)oxazin-3-ona y 7-(3-amino-2-hidroxi-propiloxi)-4h-1,3-benzoxazin-2(1h)ona |
SU772525452A SU648092A3 (ru) | 1976-01-08 | 1977-09-29 | Способ получени этерифицированных оксибензодигетероциклов или их солей, или рацематов или оптически активных антиподов |
SU772525901A SU651695A3 (ru) | 1976-01-08 | 1977-09-29 | Способ получени этерифицированных оксибензодигетероциклов или их солей, или рацематов, или оптически активных антиподов |
SU772526202A SU645568A3 (ru) | 1976-01-08 | 1977-09-29 | Способ получени этерифицированных окси-бензодигетероциклов или их солей, или рацематов или оптически активных антиподов |
CS791289A CS201041B2 (cs) | 1976-01-08 | 1979-02-26 | Způsob výroby etherifikovaných hydroxybenzodiheterocyklických sloučenin |
CS791290A CS201042B2 (cs) | 1976-01-08 | 1979-02-26 | Způsob výroby etherifikovaných hydroxybenzodiheterocyklických sloučenin |
CS791291A CS201043B2 (cs) | 1976-01-08 | 1979-02-26 | Způsob výroby etherifikovaných hydroxybenzodiheterocyklických sloučenin |
US06/018,397 US4310527A (en) | 1976-01-08 | 1979-03-08 | Etherified hydroxy quinazolone compounds |
AT194679A AT355040B (de) | 1976-01-08 | 1979-03-15 | Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - -benzoxazolonen, -benzoxazinonen, - chinazolinonen und-chinoxazolinonen |
AT194479A AT355038B (de) | 1976-01-08 | 1979-03-15 | Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, -benzoxazolonen, - -benzoxazinonen, -chinazolinonen und- chino- xazolinonen |
AT194579A AT355039B (de) | 1976-01-08 | 1979-03-15 | Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, - benzoxazolonen, -benzoxazinonen,- china- zolinonen und -chinoxazolinonen |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH16176A CH624395A5 (el) | 1976-01-08 | 1976-01-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH624395A5 true CH624395A5 (el) | 1981-07-31 |
Family
ID=4180641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH16176A CH624395A5 (el) | 1976-01-08 | 1976-01-08 |
Country Status (26)
Country | Link |
---|---|
US (2) | US4140789A (el) |
JP (1) | JPS5285166A (el) |
AR (4) | AR214869A1 (el) |
AT (1) | AT355564B (el) |
AU (1) | AU507884B2 (el) |
BE (1) | BE850166A (el) |
CA (1) | CA1083150A (el) |
CH (1) | CH624395A5 (el) |
CS (1) | CS201040B2 (el) |
DD (1) | DD129444A5 (el) |
DE (1) | DE2700193A1 (el) |
DK (1) | DK6177A (el) |
ES (1) | ES454779A1 (el) |
FI (1) | FI770036A (el) |
FR (1) | FR2337718A1 (el) |
GB (1) | GB1549945A (el) |
GR (1) | GR73132B (el) |
IE (1) | IE44246B1 (el) |
IL (1) | IL51222A (el) |
NL (1) | NL7700141A (el) |
NO (1) | NO770061L (el) |
NZ (1) | NZ182963A (el) |
PL (4) | PL112442B1 (el) |
SE (1) | SE7700056L (el) |
SU (4) | SU648091A3 (el) |
ZA (1) | ZA7787B (el) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH624395A5 (el) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag | |
DE2644833A1 (de) * | 1976-10-05 | 1978-04-20 | Boehringer Sohn Ingelheim | Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung |
NZ187066A (en) * | 1977-05-03 | 1981-02-11 | Hoffmann La Roche | 4-(3-substitutedamino-2-hydroxypropoxy)-benzimidazolidin-2-(ones or thiones) |
CA1108619A (en) * | 1977-08-12 | 1981-09-08 | Carl H. Ross | 4-hydroxy-2-benzimidazolinone derivatives and the preparation thereof |
DE2801980A1 (de) * | 1978-01-18 | 1979-07-19 | Boehringer Mannheim Gmbh | 4-hydroxy-2-benzimidazolin-thion- derivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel |
EP0003758A1 (de) * | 1978-02-09 | 1979-09-05 | Ciba-Geigy Ag | Verätherte Hydroxy-benzodiheterocyclen und ihre Säureadditionssalze, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
DE2905877A1 (de) * | 1979-02-16 | 1980-08-28 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DD150456A5 (de) * | 1979-03-01 | 1981-09-02 | Ciba Geigy Ag | Verfahren zur herstellung von derivaten des 3-amino-1,2-propandiols |
BE883068A (fr) | 1979-05-04 | 1980-08-18 | Continental Pharma | Derives de benzimidazole, leur preparation, et utilisation ainsi que compositions contenant ces derives |
DE2922084A1 (de) | 1979-05-31 | 1980-12-11 | Boehringer Mannheim Gmbh | Neue aminopropanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US4656168A (en) * | 1980-12-23 | 1987-04-07 | Merck & Co., Inc. | (3-aralkylamino-2-or-propoxy)heterocyclic compounds in method of effecting bronchodilation |
US4349673A (en) * | 1980-12-23 | 1982-09-14 | Merck & Co., Inc. | Benzoxazines |
US4442094A (en) * | 1980-12-23 | 1984-04-10 | Merck & Co., Inc. | (3-Aralkylamino-2-or-propoxy)heterocyclic compounds |
US4331679A (en) * | 1980-12-23 | 1982-05-25 | Merck Sharp & Dohme (I.A.) Corp. | (3-Aralkylamino-2-or-propoxy) heterocyclic compounds |
DE3217012A1 (de) * | 1982-05-06 | 1983-11-10 | Dr. Karl Thomae Gmbh, 7950 Biberach | Benzoxazin-2-one, deren herstellung und diese verbindungen enthaltende arzneimittel |
IT1212552B (it) * | 1982-10-20 | 1989-11-30 | Italo Britannica L Manet Ti H | Alcanolaminossi derivati di 3,4-diidro-2h-1.4-benzotiazin-3-one, loro procedimento di produzione e loro utilizzazione farmaceutica |
GB8419797D0 (en) * | 1984-08-03 | 1984-09-05 | Beecham Group Plc | Compounds |
DE3800096A1 (de) * | 1988-01-05 | 1989-07-13 | Bayer Ag | Verwendung von benzimidazolderivaten als leistungsfoerderer |
FR2653430B1 (fr) * | 1989-10-23 | 1991-12-20 | Pf Medicament | Nouveaux derives de dihydro-1,2 oxo-2 quinoxalines, leur preparation et leur application en therapeutique. |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
DE69711519T2 (de) | 1996-09-05 | 2002-10-31 | Eli Lilly And Co., Indianapolis | Carbazolanaloge als selektive beta3-adrenergische Agonisten |
US5808080A (en) * | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
US5922715A (en) * | 1997-02-18 | 1999-07-13 | American Home Products Corporation | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones |
US5972958A (en) * | 1997-02-18 | 1999-10-26 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydro-benzoimidazol-2-thiones |
US5990144A (en) * | 1997-02-18 | 1999-11-23 | American Home Products Corporation | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists |
DE59804641D1 (de) | 1997-09-24 | 2002-08-08 | Infineon Technologies Ag | o-Nitro(thio)phenolderivate und deren Herstellung |
CO5011072A1 (es) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | Etanolaminas pirazinil substituidas como agfonistas de los receptores |
WO2001036412A1 (en) * | 1999-11-15 | 2001-05-25 | Eli Lilly And Company | Process for the preparation of aryloxy propanolamines |
FR2805159B1 (fr) | 2000-02-23 | 2005-06-10 | Oreal | Compositions pour la teinture d'oxydation des fibres keratiniques comprenant un n-(2-hydroxybenzene)-carbamate ou un n-(2-hydroxybenzene)-uree a titre de coupleur, et procedes de teinture |
DE60120748T2 (de) | 2000-11-10 | 2007-05-16 | Eli Lilly And Co., Indianapolis | 3-substituierte oxindolderivate als beta-3-agonisten |
DE60215028T2 (de) | 2001-08-14 | 2007-03-15 | Eli Lilly And Co., Indianapolis | Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes |
ATE325119T1 (de) | 2001-08-14 | 2006-06-15 | Lilly Co Eli | 3-substituierte oxindol-beta-3-agonisten |
WO2003044016A1 (en) | 2001-11-20 | 2003-05-30 | Eli Lilly And Company | 3-SUBSTITUTED OXINDOLE β3 AGONISTS |
EP1448561B1 (en) | 2001-11-20 | 2008-02-20 | Eli Lilly And Company | Beta 3 adrenergic agonists |
JP2005520805A (ja) * | 2002-01-11 | 2005-07-14 | イーライ・リリー・アンド・カンパニー | 2−オキソ−ベンズイミダゾリル置換型エタノールアミン誘導体およびβ3アゴニストとしてのその使用 |
WO2004020428A1 (ja) * | 2002-08-29 | 2004-03-11 | Nissan Chemical Industries, Ltd. | アミノベンゾピラン化合物の製造方法 |
WO2005009993A1 (en) * | 2003-07-15 | 2005-02-03 | Smithkline Beecham Corporation | Novel compounds |
KR101129868B1 (ko) * | 2006-10-04 | 2012-04-12 | 화이자 프로덕츠 인코포레이티드 | 칼슘 수용체 길항제로서의 피리도[4,3-d]피리미딘-4(3H)-온 유도체 |
US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA726737A (en) * | 1966-01-25 | C. Scarborough Homer | 4-substituted quinolines and quinazolines | |
US3686176A (en) * | 1970-03-09 | 1972-08-22 | Frosst & Co Charles E | 1-morpholino phenoxy-3-alkylamino-2-propanols |
US3763153A (en) * | 1972-02-22 | 1973-10-02 | Squibb & Sons Inc | Benzothiazines |
GB1488330A (en) * | 1973-12-19 | 1977-10-12 | Smith Kline French Lab | Dihydropyridazinones |
CH624395A5 (el) * | 1976-01-08 | 1981-07-31 | Ciba Geigy Ag |
-
1976
- 1976-01-08 CH CH16176A patent/CH624395A5/de not_active IP Right Cessation
- 1976-12-16 US US05/751,233 patent/US4140789A/en not_active Expired - Lifetime
- 1976-12-21 AR AR265940A patent/AR214869A1/es active
- 1976-12-22 NZ NZ182963A patent/NZ182963A/xx unknown
- 1976-12-22 GB GB53633/76A patent/GB1549945A/en not_active Expired
-
1977
- 1977-01-04 DE DE19772700193 patent/DE2700193A1/de not_active Withdrawn
- 1977-01-04 SE SE7700056A patent/SE7700056L/xx unknown
- 1977-01-04 ES ES454779A patent/ES454779A1/es not_active Expired
- 1977-01-06 PL PL1977214710A patent/PL112442B1/pl unknown
- 1977-01-06 PL PL1977214708A patent/PL112491B1/pl unknown
- 1977-01-06 DD DD7700196843A patent/DD129444A5/xx unknown
- 1977-01-06 PL PL1977195154A patent/PL110654B1/pl unknown
- 1977-01-06 IL IL51222A patent/IL51222A/xx unknown
- 1977-01-06 FI FI770036A patent/FI770036A/fi not_active Application Discontinuation
- 1977-01-06 FR FR7700232A patent/FR2337718A1/fr active Granted
- 1977-01-06 AU AU21105/77A patent/AU507884B2/en not_active Expired
- 1977-01-06 CA CA269,205A patent/CA1083150A/en not_active Expired
- 1977-01-06 PL PL1977214709A patent/PL112441B1/pl unknown
- 1977-01-07 ZA ZA770087A patent/ZA7787B/xx unknown
- 1977-01-07 CS CS77117A patent/CS201040B2/cs unknown
- 1977-01-07 AT AT4677A patent/AT355564B/de not_active IP Right Cessation
- 1977-01-07 SU SU772435952A patent/SU648091A3/ru active
- 1977-01-07 NO NO770061A patent/NO770061L/no unknown
- 1977-01-07 IE IE31/77A patent/IE44246B1/en unknown
- 1977-01-07 NL NL7700141A patent/NL7700141A/xx not_active Application Discontinuation
- 1977-01-07 DK DK6177A patent/DK6177A/da unknown
- 1977-01-07 BE BE173895A patent/BE850166A/xx unknown
- 1977-01-08 GR GR52536A patent/GR73132B/el unknown
- 1977-01-08 JP JP55977A patent/JPS5285166A/ja active Pending
- 1977-08-02 AR AR268662A patent/AR217258A1/es active
- 1977-08-02 AR AR268660A patent/AR214746A1/es active
- 1977-08-02 AR AR268661A patent/AR215643A1/es active
- 1977-09-29 SU SU772526202A patent/SU645568A3/ru active
- 1977-09-29 SU SU772525901A patent/SU651695A3/ru active
- 1977-09-29 SU SU772525452A patent/SU648092A3/ru active
-
1979
- 1979-03-08 US US06/018,397 patent/US4310527A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH624395A5 (el) | ||
DE69721526T2 (de) | Benzofuran carboxamide und ihre therapeutische anwendung | |
EP0339416B1 (de) | Gegebenenfalls alpha-substituierte 4-(Chinolin-2-yl-methoxy)phenylessigsäuren und -ester | |
CH629778A5 (de) | Verfahren zur herstellung neuer 1,4-dihydropyridinderivate. | |
EP0174654A2 (de) | Carbonylverbindungen | |
DE68906200T2 (de) | Kondensierte pyrazol-3-oxo-propannitril-derivate und verfahren zu deren herstellung. | |
CH636099A5 (de) | Verfahren zur herstellung von piperidinopropanolderivaten. | |
EP0220573B1 (de) | Heterocyclische Verbindungen | |
DE3739882A1 (de) | Substituierte hydroxylamine | |
DE2313227A1 (de) | Neue isoindolinderivate, ihre herstellung und die medizinischen zusammensetzungen, die sie enthalten | |
WO1983004254A1 (en) | Piperazine derivative compounds, production method thereof and drugs containing them | |
DE68924221T2 (de) | Imidazolderivate. | |
EP0298921B1 (de) | 1,2-Benzisoxazole und 1,2-Benzisothiazole | |
DE3900028A1 (de) | Gegebenenfalls am phenylrest halogen- und/oder alkyl- und/oder alkoxy- oder methylendioxysubstituierte, 5,5-di-(methyl)-3-(phenylvinyl)-1-(substituiert amino-alkoxy-imino)-cyclohex-2-enderivate, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel | |
DE4117750A1 (de) | Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln | |
DD238790A5 (de) | Verfahren zur herstellung von 3-amino carbonylmethoxy-5-phenylpyrazol-verbindungen | |
EP0018360A1 (de) | N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung. | |
DE3300522C2 (el) | ||
Savini et al. | EVALUATION OF ANTIINFLAMMATORY AND ANALGESIC PROPERTIES. II. | |
DE19932314A1 (de) | Benzofuranderivate | |
EP0062919B1 (de) | Neue Indol-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten | |
DE69223422T2 (de) | Benzothiadiazinderivate | |
EP0110298B1 (de) | Acridanon-Derivate | |
AT355038B (de) | Verfahren zur herstellung von neuen veraetherten hydroxy-benzimidazolonen, -benzoxazolonen, - -benzoxazinonen, -chinazolinonen und- chino- xazolinonen | |
DD143910A5 (de) | Verfahren zur herstellung von pyridopyrimidinen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |